0001209191-18-050900.txt : 20180913
0001209191-18-050900.hdr.sgml : 20180913
20180913171142
ACCESSION NUMBER: 0001209191-18-050900
CONFORMED SUBMISSION TYPE: 3
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20180913
FILED AS OF DATE: 20180913
DATE AS OF CHANGE: 20180913
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: MORGENTHALER VENTURE PARTNERS IX LP
CENTRAL INDEX KEY: 0001439101
STATE OF INCORPORATION: DE
FILING VALUES:
FORM TYPE: 3
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38653
FILM NUMBER: 181069458
BUSINESS ADDRESS:
STREET 1: 2710 SAND HILL ROAD
STREET 2: SUITE 100
CITY: MENLO PARK
STATE: CA
ZIP: 94025
BUSINESS PHONE: 650-388-7600
MAIL ADDRESS:
STREET 1: 2710 SAND HILL ROAD
STREET 2: SUITE 100
CITY: MENLO PARK
STATE: CA
ZIP: 94025
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Morgenthaler Management Partners IX, LLC
CENTRAL INDEX KEY: 0001666860
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 3
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38653
FILM NUMBER: 181069459
BUSINESS ADDRESS:
STREET 1: 3200 ALPINE ROAD
CITY: PORTOLA VALLEY
STATE: CA
ZIP: 94028
BUSINESS PHONE: 650-388-7600
MAIL ADDRESS:
STREET 1: 3200 ALPINE ROAD
CITY: PORTOLA VALLEY
STATE: CA
ZIP: 94028
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Principia Biopharma Inc.
CENTRAL INDEX KEY: 0001510487
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 263487603
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 400 EAST JAMIE COURT, SUITE 302
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
BUSINESS PHONE: (650) 416-7700
MAIL ADDRESS:
STREET 1: 400 EAST JAMIE COURT, SUITE 302
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
3
1
doc3.xml
FORM 3 SUBMISSION
X0206
3
2018-09-13
0
0001510487
Principia Biopharma Inc.
PRNB
0001439101
MORGENTHALER VENTURE PARTNERS IX LP
3200 ALPINE ROAD
PORTOLA VALLEY
CA
94028
0
0
1
0
0001666860
Morgenthaler Management Partners IX, LLC
3200 ALPINE ROAD
PORTOLA VALLEY
CA
94028
0
0
1
0
Series A Preferred Stock
0.00
Common Stock
1070771
D
Series B-1 Preferred Stock
0.00
Common Stock
312741
D
Series B-2 Preferred Stock
0.00
Common Stock
260617
D
Series B-3 Preferred Stock
0.00
Common Stock
544047
D
Series C Preferred Stock
0.00
Common Stock
6949
D
Warrant to Purchase Series B-3 Preferred Stock
8.9931
2022-12-29
Series B-3 Preferred Stock
28623
D
Each share of Preferred Stock will be automatically converted into one (1) share of Common Stock, for no additional consideration, immediately prior to the consummation of the Issuer's initial public offering, and has no expiration date.
The securities are held by Morgenthaler Venture Partners IX, L.P. ("MVP IX"). The general partner of MVP IX is Morgenthaler Management Partners IX, LLC ("MMP IX"). MMP IX may be deemed to indirectly beneficially own the securities directly held by MVP IX. MMP IX disclaims beneficial ownership of the securities held by MVP IX except to the extent of its pecuniary interest therein.
This warrant is exercisable at any time.
Morgenthaler Venture Partners IX, L.P., By: Morgenthaler Management Partners IX, LLC, its General Partner, By: /s/ Travis Boettner, Chief Financial Officer and Chief Compliance Officer
2018-09-13
Morgenthaler Management Partners IX, LLC, by /s/ Travis Boettner, Chief Financial Officer & Chief Compliance Officer
2018-09-13